FTX founder Sam Bankman-Fried denies stealing person funds and repeats claims of solvency in new write-up

FTX founder Sam Bankman-Fried denies stealing person funds and repeats claims of solvency in new write-up


Critical Details
  • FTX co-founder Sam Bankman-Fried denied federal allegations that he misappropriated $8 billion in purchaser belongings, months ahead of his federal demo on fraud, money laundering and campaign finance fees.
  • Bankman-Fried recurring a number of statements that personal bankruptcy officers and federal regulators have denied or contradicted, together with that FTX US stays solvent and that the collapse of his hedge fund Alameda Exploration was owing to broader sector turbulence.
  • The 30-calendar year-old’s New York federal demo will begin in October.



Supply

Stocks making the biggest moves premarket: CME Group, Tilray Brands, SanDisk & more
Finance

Stocks making the biggest moves premarket: CME Group, Tilray Brands, SanDisk & more

Check out the companies making headlines before the bell. SanDisk — The maker of flash memory products, including memory cards, climbed more than 4%. The stock, spun off from Western Digita l last February, enters the S & P 500 on Friday. Tilray Brands — The cannabis processor and owner of Montauk Brewing slid 14% […]

Read More
‘Green light’ away from AI trade: Two ETF executives see a key market shift underway
Finance

‘Green light’ away from AI trade: Two ETF executives see a key market shift underway

ETF Edge ‘Green light’ away from AI trade: Two ETF executives see a key market shift underway Published Thu, Nov 27 20254:00 PM EST Krysta Escobar WATCH LIVE Source

Read More
Stocks making the biggest moves midday: Dell, Arrowhead Pharmaceuticals, Urban Outfitters & more
Finance

Stocks making the biggest moves midday: Dell, Arrowhead Pharmaceuticals, Urban Outfitters & more

Check out the companies making the biggest moves midday: Arrowhead Pharmaceuticals — The stock popped 19% after the biopharmaceutical company reported fiscal year revenue that beat analyst expectations. Arrowhead’s top line for the period totaled $829.4 million, beating a FactSet consensus of $861.2 million. Last week, the company announced it created the first and only […]

Read More